Cited by 409Dementia and Cognitive Impairment ResearchAmyotrophic Lateral Sclerosis ResearchAlzheimer's disease research and treatments

Typical and atypical pathology in primary progressive aphasia variants

Open access
Spinelli, Edoardo G., Mandelli, Maria Luisa, Miller, Zachary A., Santos‐Santos, Miguel A, Wilson, Stephen M., Agosta, Federica, Grinberg, Lea T., Huang, Eric J. +10 more·2017·Annals of Neurology

Abstract

Objective: To characterize in vivo signatures of pathological diagnosis in a large cohort of patients with primary progressive aphasia (PPA) variants defined by current diagnostic classification. Methods: Extensive clinical, cognitive, neuroimaging, and neuropathological data were collected from 69 patients with sporadic PPA, divided into 29 semantic (svPPA), 25 nonfluent (nfvPPA), 11 logopenic (lvPPA), and 4 mixed PPA. Patterns of gray matter (GM) and white matter (WM) atrophy at presentation were assessed and tested as predictors of pathological diagnosis using support vector machine (SVM) algorithms. Results: A clinical diagnosis of PPA was associated with frontotemporal lobar degeneration (FTLD) with transactive response DNA‐binding protein (TDP) inclusions in 40.5%, FTLD‐tau in 40.5%, and Alzheimer disease (AD) pathology in 19% of cases. Each variant was associated with 1 typical pathology; 24 of 29 (83%) svPPA showed FTLD‐TDP type C, 22 of 25 (88%) nfvPPA showed FTLD‐tau, and all 11 lvPPA had AD. Within FTLD‐tau, 4R‐tau pathology was commonly associated with nfvPPA, whereas Pick disease was observed in a minority of subjects across all variants except for lvPPA. Compared with pathologically typical cases, svPPA‐tau showed significant extrapyramidal signs, greater executive impairment, and severe striatal and frontal GM and WM atrophy. nfvPPA‐TDP patients lacked general motor symptoms or significant WM atrophy. Combining GM and WM volumes, SVM analysis showed 92.7% accuracy to distinguish FTLD‐tau and FTLD‐TDP pathologies across variants. Interpretation: Each PPA clinical variant is associated with a typical and most frequent cognitive, neuroimaging, and neuropathological profile. Specific clinical and early anatomical features may suggest rare and atypical pathological diagnosis in vivo. Ann Neurol 2017;81:430–443

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ana.24885

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 48

  1. [1]Gorno-Tempini ML Hillis AE Weintraub S Classification of primary progressive aphasia and its variants Neurology 2011 3 15 76 11 1006 14 21325651 PMC3059138
  2. [2]Chare L Hodges JR Leyton CE New criteria for frontotemporal dementia syndromes: clinical and pathological diagnostic implications Journal of neurology, neurosurgery, and psychiatry 2014 8 85 8 865 70 24421286
  3. [4]Mesulam MM Weintraub S Rogalski EJ Wieneke C Geula C Bigio EH Asymmetry and heterogeneity of Alzheimer’s and frontotemporal pathology in primary progressive aphasia Brain: a journal of neurology 2014 4 137 Pt 4 1176 92 24574501 PMC3959558
  4. [5]Grossman M Primary progressive aphasia: clinicopathological correlations Nature reviews Neurology 2010 2 6 2 88 97 20139998 PMC3637977
  5. [6]Harris JM Gall C Thompson JC Classification and pathology of primary progressive aphasia Neurology 2013 11 19 81 21 1832 9 24142474
  6. [7]Rohrer JD Lashley T Schott JM Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration Brain: a journal of neurology 2011 9 134 Pt 9 2565 81 21908872 PMC3170537
  7. [8]Deramecourt V Lebert F Debachy B Prediction of pathology in primary progressive language and speech disorders Neurology 2010 1 5 74 1 42 9 19940270
  8. [9]Josephs KA Duffy JR Strand EA Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech Brain: a journal of neurology 2006 6 129 Pt 6 1385 98 16613895 PMC2748312
  9. [10]Knibb JA Xuereb JH Patterson K Hodges JR Clinical and pathological characterization of progressive aphasia Annals of neurology 2006 1 59 1 156 65 16374817
  10. [11]Kertesz A McMonagle P Blair M Davidson W Munoz DG The evolution and pathology of frontotemporal dementia Brain: a journal of neurology 2005 9 128 Pt 9 1996 2005 16033782
  11. [12]Josephs KA Dickson DW Murray ME Quantitative neurofibrillary tangle density and brain volumetric MRI analyses in Alzheimer’s disease presenting as logopenic progressive aphasia Brain and language 2013 11 127 2 127 34 23541297 PMC3840097
  12. [13]Rohrer JD Rossor MN Warren JD Alzheimer’s pathology in primary progressive aphasia Neurobiology of aging 2012 4 33 4 744 52 20580129 PMC3314936
  13. [14]Leyton CE Britton AK Hodges JR Halliday GM Kril JJ Distinctive pathological mechanisms involved in primary progressive aphasias Neurobiology of aging 2016 2 38 82 92 26827646
  14. [15]Clark CN Lashley T Mahoney CJ Warren JD Revesz T Rohrer JD Temporal Variant Frontotemporal Dementia is Associated with Globular Glial Tauopathy Cognitive and behavioral neurology: official journal of the Society for Behavioral and Cognitive Neurology 2015 6 28 2 92 7 26102999 PMC4478068
  15. [16]Rohrer JD Geser F Zhou J TDP-43 subtypes are associated with distinct atrophy patterns in frontotemporal dementia Neurology 2010 12 14 75 24 2204 11 21172843 PMC3013589
  16. [17]Hodges JR Mitchell J Dawson K Semantic dementia: demography, familial factors and survival in a consecutive series of 100 cases Brain: a journal of neurology 2010 1 133 Pt 1 300 6 19805492
  17. [18]Rabinovici GD Jagust WJ Furst AJ Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia Annals of neurology 2008 10 64 4 388 401 18991338 PMC2648510
  18. [19]Leyton CE Villemagne VL Savage S Subtypes of progressive aphasia: application of the International Consensus Criteria and validation using beta-amyloid imaging Brain: a journal of neurology 2011 10 134 Pt 10 3030 43 21908392
  19. [20]Teichmann M Kas A Boutet C Deciphering logopenic primary progressive aphasia: a clinical, imaging and biomarker investigation Brain: a journal of neurology 2013 11 136 Pt 11 3474 88 24108322
  20. [21]Kloppel S Peter J Ludl A Applying Automated MR-Based Diagnostic Methods to the Memory Clinic: A Prospective Study Journal of Alzheimer’s disease: JAD 2015 47 4 939 54 26401773 PMC4923764
  21. [22]Cherubini A Morelli M Nistico R Magnetic resonance support vector machine discriminates between Parkinson disease and progressive supranuclear palsy Movement disorders: official journal of the Movement Disorder Society 2014 2 29 2 266 9 24323617
  22. [23]Wilson SM Ogar JM Laluz V Automated MRI-based classification of primary progressive aphasia variants NeuroImage 2009 10 1 47 4 1558 67 19501654 PMC2719687
  23. [24]Gorno-Tempini ML Dronkers NF Rankin KP Cognition and anatomy in three variants of primary progressive aphasia Annals of neurology 2004 3 55 3 335 46 14991811 PMC2362399
  24. [25]Moreno F Rabinovici GD Karydas A A novel mutation P112H in the TARDBP gene associated with frontotemporal lobar degeneration without motor neuron disease and abundant neuritic amyloid plaques Acta neuropathologica communications 2015 3 19 25853458 PMC4382926
  25. [26]Li Y Chen JA Sears RL An epigenetic signature in peripheral blood associated with the haplotype on 17q21.31, a risk factor for neurodegenerative tauopathy PLoS genetics 2014 3 10 3 e1004211 24603599 PMC3945475
  26. [27]Kramer JH Jurik J Sha SJ Distinctive neuropsychological patterns in frontotemporal dementia, semantic dementia, and Alzheimer disease Cognitive and behavioral neurology: official journal of the Society for Behavioral and Cognitive Neurology 2003 12 16 4 211 8 14665820
  27. [28]Mackenzie IR Neumann M Bigio EH Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update Acta neuropathologica 2010 1 119 1 1 4 19924424 PMC2799633
  28. [29]Consensus recommendations for the postmortem diagnosis of Alzheimer’s disease The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer’s Disease Neurobiology of aging 1997 Jul-Aug 18 4 Suppl S1 2 9330978
  29. [30]McKeith IG Galasko D Kosaka K Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop Neurology 1996 11 47 5 1113 24 8909416
  30. [31]Mandelli ML Vitali P Santos M Two insular regions are differentially involved in behavioral variant FTD and nonfluent/agrammatic variant PPA Cortex; a journal devoted to the study of the nervous system and behavior 2015 11 14 74 149 57 26673947 PMC4755480
  31. [32]Zhang Y Schuff N Ching C Joint assessment of structural, perfusion, and diffusion MRI in Alzheimer’s disease and frontotemporal dementia International journal of Alzheimer’s disease 2011 2011 546871 PMC3132541 21760989
  32. [33]Ashburner J Friston KJ Unified segmentation NeuroImage 2005 7 1 26 3 839 51 15955494
  33. [34]Ashburner J A fast diffeomorphic image registration algorithm NeuroImage 2007 10 15 38 1 95 113 17761438
  34. [36]Spinelli EG Caso F Agosta F A multimodal neuroimaging study of a case of crossed nonfluent/agrammatic primary progressive aphasia Journal of neurology 2015 10 262 10 2336 45 26194195 PMC5757514
  35. [37]Caso F Mandelli ML Henry M In vivo signatures of nonfluent/agrammatic primary progressive aphasia caused by FTLD pathology Neurology 2014 1 21 82 3 239 47 24353332 PMC3902758
  36. [38]Catani M Mesulam MM Jakobsen E A novel frontal pathway underlies verbal fluency in primary progressive aphasia Brain: a journal of neurology 2013 8 136 Pt 8 2619 28 23820597 PMC3722349
  37. [39]Gorno-Tempini ML Brambati SM Ginex V The logopenic/phonological variant of primary progressive aphasia Neurology 2008 10 14 71 16 1227 34 18633132 PMC2676989
  38. [40]Rabinovici GD Rosen HJ Alkalay A Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD Neurology 2011 12 6 77 23 2034 42 22131541 PMC3236517
  39. [41]Leyton CE Hodges JR McLean CA Kril JJ Piguet O Ballard KJ Is the logopenic-variant of primary progressive aphasia a unitary disorder? Cortex; a journal devoted to the study of the nervous system and behavior 2015 6 67 122 33 25955499
  40. [42]Rosen HJ Allison SC Schauer GF Gorno-Tempini ML Weiner MW Miller BL Neuroanatomical correlates of behavioural disorders in dementia Brain: a journal of neurology 2005 11 128 Pt 11 2612 25 16195246 PMC1820861
  41. [43]McMillan CT Irwin DJ Avants BB White matter imaging helps dissociate tau from TDP-43 in frontotemporal lobar degeneration Journal of neurology, neurosurgery, and psychiatry 2013 9 84 9 949 55 PMC3737288 23475817
  42. [44]Agosta F Galantucci S Magnani G MRI signatures of the frontotemporal lobar degeneration continuum Human brain mapping 2015 7 36 7 2602 14 25821176 PMC6869605
  43. [45]Liu L Drouet V Wu JW Trans-synaptic spread of tau pathology in vivo PloS one 2012 7 2 e31302 22312444 PMC3270029
  44. [46]Clavaguera F Akatsu H Fraser G Brain homogenates from human tauopathies induce tau inclusions in mouse brain Proceedings of the National Academy of Sciences of the United States of America 2013 6 4 110 23 9535 40 23690619 PMC3677441
  45. [47]Nonaka T Masuda-Suzukake M Arai T Prion-like properties of pathological TDP-43 aggregates from diseased brains Cell reports 2013 7 11 4 1 124 34 23831027
  46. [48]Brettschneider J Del Tredici K Irwin DJ Sequential distribution of pTDP-43 pathology in behavioral variant frontotemporal dementia (bvFTD) Acta neuropathologica 2014 3 127 3 423 39 24407427 PMC3971993
  47. [49]Seeley WW Crawford RK Zhou J Miller BL Greicius MD Neurodegenerative diseases target large-scale human brain networks Neuron 2009 4 16 62 1 42 52 19376066 PMC2691647
  48. [50]Staekenborg SS Pijnenburg YA Lemstra AW Scheltens P Vd Flier WM Dementia and Rapid Mortality: Who is at Risk? Journal of Alzheimer’s disease: JAD 2016 4 19 27104894

Cited by

Sorted by citations

Authors
Spinelli, E. G., Mandelli, M. L., Miller, Z. A., Santos‐Santos, M. A., Wilson, S. M., Agosta, F., Grinberg, L. T., Huang, E. J., Trojanowski, J. Q., Meyer, M., Henry, M. L., Comi, G., Rabinovici, G., Rosen, H. J., Filippi, M., Miller, B. L., Seeley, W. W., & Gorno‐Tempini, M. L.
Affiliations
  • Vita-Salute San Raffaele University (IT)
  • University of California, San Francisco (US)
  • University of Pennsylvania (US)
  • The University of Texas at Austin (US)
  • Neuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Scientific Institute Vita‐Salute San Raffaele University Milan Italy
Corresponding author
Gorno‐Tempini, Maria Luisa
Venue
Annals of Neurology
Publisher
Wiley
Published
2017-03
Volume
81
Issue
3
Pages
430-443
ISSN
  • 0364-5134 (ISSN-L)
  • 1531-8249
OpenAlex
W2582619151
Cited by
409
References
2
Citations by year
2026: 25 · 2025: 51 · 2024: 35 · 2023: 36 · 2022: 53 · 2021: 50 · 2020: 73 · 2019: 42 · 2018: 29 · 2017: 15
FWCI
35.73
Type
journal article
Language
en
Open access
Locations
  • Annals of Neurology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
  • Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion, other-oa)
Funders
  • National Institute of Neurological Disorders and Stroke (R01 NS050915)
  • National Institute on Deafness and Other Communication Disorders (K24 DC015544)
  • National Institute on Aging (P50 AG03006, P50 AG023501, P01 AG019724)
  • Larry L. Hillblom Foundation
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
Keywords
primary progressive aphasia, semantic variant PPA, logopenic variant PPA, frontotemporal lobar degeneration, FTLD-TDP, FTLD-tau, Alzheimer disease pathology, Pick's disease, 4R tau, gray matter atrophy, white matter atrophy, neuropathological diagnosis, support vector machine classification, extrapyramidal signs
MeSH terms
Aged, Aged, 80 and over, Alzheimer Disease, Atrophy, Female, Humans, Male, Middle Aged, tau Proteins, Aphasia, Primary Progressive, Pick Disease of the Brain, Frontotemporal Lobar Degeneration, Primary Progressive Nonfluent Aphasia, Support Vector Machine, White Matter, Gray Matter

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review